| Literature DB >> 22916309 |
Hyoung Kyu Kim1, Won Sun Park, Mohamad Warda, So Youn Park, Eun A Ko, Min Hee Kim, Seung Hun Jeong, Hye-Jin Heo, Tae-Hoon Choi, Young-Won Hwang, Sun-Il Lee, Kyung Soo Ko, Byoung Doo Rhee, Nari Kim, Jin Han.
Abstract
BACKGROUND ANDEntities:
Mesh:
Substances:
Year: 2012 PMID: 22916309 PMCID: PMC3423383 DOI: 10.1371/journal.pone.0043884
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Hemodynamic characterization of experimental animals.
| Con | ISO | |
|
| 1.66±0.08 | 1.78±0.06 |
|
|
|
|
|
|
|
|
|
| ||
| Systolic | 122.66±1.13 | 119.46±2.07 |
| Diastolic | 58.41±3.19 | 54.20±7.54 |
| Mean arterial pressure | 82.08±3.93 | 81.00±3.82 |
|
| 212.33±18.80 | 256.20±7.83 |
Means ± SE (n = 5) *P<0.05, student T-test.
Figure 1Comparative two dimensional gel electrophoresis (2DE) analysis of control and ISO-CAs.
A. 2DE gel images of control (up) and ISO-CAs (down) with proteins of interest annotated. B. Enlarged spot images and histograms of significantly (n = 3 in each group, Student's t-test, *P<0.05 vs. control) altered protein expression. The protein spots were selected from ‘Cytoskeleton and organization’ and ‘Posttranslational modification, chaperones’ categories. C. Major biological processes of identified proteins. D. Major molecular function of identified proteins. Proteome categorized by Protein ANalysis THrough Evolutionary Relationships (PANTHER) algorithm.
Functional category and expression changes of identified proteins.
| Identification & functional category | Relative protein level in ISO | p-value | NCBI GI |
|
| |||
| Glutamate dehydrogenase (GLUD1) | 0.59 | 0.032 | 51863477 |
|
| |||
| Vimentin (VIM) | 0.36 | 0.048 | 860908 |
| Septin (SEPT8) | 0.34 | 0.009 | 27448554 |
|
| |||
| GRIP1 associated protein 1 (GRIPAP1) | 0.29 | 0.045 | 74196422 |
| WD repeat-containing protein 1 isoform 8 (WDR1) | 0.56 | 0.038 | 114593211 |
| Coronin-1B (CORO1B) | 0.37 | 0.048 | 54035918 |
| Actin-related protein 1 (ACTR1A) | 0.5 | 0.043 | 381964 |
| Actin-related protein 2 homolog (ACTR2) | 0.47 | 0.013 | 29126784 |
| Alpha-actin (ACTC1) | 0.37 | 0.025 | 49870 |
| Capping protein (actin filament) muscle Z-line (CAPZB) | 0.55 | 0.05 | 119615295 |
| Actin, alpha 2, smooth muscle (ACTA20 | 0.54 | 0.023 | 178027 |
|
| |||
| NADH dehydrogenase (ubiquinone) Fe-S protein 1 (NDUFS1) | 2.06 | 0.039 | 53850628 |
| NADH dehydrogenase (ubiquinone) Fe-S protein 8 (NDUFS8) | 0.39 | 0.034 | 157821497 |
| Aldehyde dehydrogenase 1A2 isoform 1 (RALDH2) | 0.37 | 0.048 | 50369993 |
| Aldehyde dehydrogenase family 1 member A1 (ALDH1A1) | 0.38 | 0.025 | 42558920 |
| Aldehyde dehydrogenase, mitochondrial precursor (ALDH2) | 0.54 | 0.033 | 73995214 |
| Isocitrate dehydrogenase 1 (NADP+) (IDH1) | 0.74 | 0.046 | 13928690 |
|
| |||
| Alpha-2 collagen type VI (COL6A2) | 0.51 | 0.044 | 49907 |
|
| |||
| Moesin (MSN) | 0.32 | 0.031 | 13540689 |
|
| |||
| Annexin VI isoform 1 (ANX6) | 0.38 | 0.044 | 71773329 |
| Annexin A1 (Annexin I) (ANXA1) | 0.59 | 0.033 | 1703316 |
|
| |||
| Dihydropyrimidinase-like 2 (DPYSL2) | 0.42 | 0.049 | 115496400 |
|
| |||
| Heat shock protein 9A, mortalin (HSPA9) | 0.42 | 0.032 | 6754256 |
| Stress-induced-phosphoprotein 1 (STIP1) | 0.55 | 0.047 | 73983760 |
| Protein disulfide isomerase family A, member 3, (PDIA3) | 0.42 | 0.033 | 119597640 |
| Chaperonin containing TCP1, subunit 2 (beta), (CCT2) | 0.49 | 0.029 | 119617634 |
| GDP dissociation inhibitor 2 (GDI2) | 0.37 | 0.039 | 40254781 |
| Elongation factor 1-gamma (EF1G) | 0.25 | 0.021 | 232037 |
| Glutathione-S-transferase, mu 5 (GSTM5) | 1.98 | 0.046 | 25282395 |
|
| |||
| EH-domain containing 1, isoform CRA_a (EHD1) | 0.73 | 0.041 | 119594723 |
| Serine/threonine-protein phosphatase PP1-beta catalytic subunit (PP-1B) (SPDYA) | 0.49 | 0.037 | 109102505 |
|
| |||
| Albumin (ALB) | 0.46 | 0.029 | 30794280 |
Figure 2Western blot analysis of selected proteins from control and ISO-CAs.
A. Representative western blot images of five down-regulated major cytoskeleton related proteins and two up-regulated non-cytoskeletal proteins. B. The relative expression rate of target proteins in control and ISO-CAs was analyzed by densitometry (n = 3 in each group, Student's t-test, *P<0.05 vs. control). C. IHC image of α SMC. C. α-smooth muscle actin expression was determined by Immunohistochemistry in Con and ISO-CAs. Sliced cerebral artery tissues were co-stained with DAPI and α-actin specific antibody. Scale bar: 50 μm.
Figure 3Functional association network analysis of 2D MS identified proteins.
A. Protein–protein interactions among the 30 identified proteins were analyzed using STRING 8.0. Twelve of the proteins were functionally associated with the major cytoskeletal network. B. Extended network prediction provides possible interacting partners of the subjected proteins. ACTC1 = actin, alpha cardiac muscle 1; ACTG2 = actin, gamma-enteric smooth muscle; ACTR1A = alpha-centractin (centractin); ACTR2 = actin-like protein 2 (actin-related protein 2); ADH3 = alcohol dehydrogenase 1B; ADHFE1 = alcohol dehydrogenase, iron containing, 1; ALDH1A1 = retinal dehydrogenase 1; ALDH2 = aldehyde dehydrogenase, mitochondrial precursor; ANX6 = annexin A6; ANXA1 = annexin A1; ARC21 = actin-related protein 2/3 complex subunit 3; ARC41 = actin-related protein 2/3 complex subunit 1B; ARPC2 = actin-related protein 2/3 complex subunit 2; ARPC5 = actin-related protein 2/3 complex subunit 5; CAPZA2 = F-actin capping protein subunit alpha-2; CAPZB = F-actin capping protein subunit beta; CASP3 = caspase-3 precursor; CCT2 = T-complex protein 1 subunit beta; CORO1B = coronin-1B; DPYSL2 = dihydropyrimidinase-related protein 2; FPR = fMet-Leu-Phe receptor; GLUD1 = glutamate dehydrogenase 1, mitochondrial precursor; GRIPAP1 = GRIP1-associated protein 1; GSTM5 = glutathione S-transferase Mu 5; HSP90AA1 = heat shock protein HSP 90-alpha; HSPA9 = stress-70 protein, mitochondrial precursor; MSN = moesin (membrane-organizing extension spike protein); NDUFS1 = NADH-ubiquinone oxidoreductase 75 kDa subunit; NDUFS8 = NADH dehydrogenase iron-sulfur protein 8; NDUFV2 = NADH dehydrogenase flavoprotein 2; NHERF = ezrin-radixin-moesin-binding phosphoprotein 50; PDIA3 = protein disulfide-isomerase A3 precursor; RALDH2 = retinal dehydrogenase 2; RO = calreticulin precursor (CRP55) (calregulin); RhoA = Ras homolog gene family, member A; ROCK1 = Rho-associated, coiled-coil containing protein kinase 1; S100A11 = protein S100-A11 (S100 calcium-binding protein A11) (calgizzarin) (MLN 70); SPDYA = serine/threonine-protein phosphatase PP1-beta catalytic subunit; STIP1 = stress-induced-phosphoprotein 1; TTLL3 = tubulin–tyrosine ligase-like protein 3; VIM = vimentin; WDR1 = WD repeat protein 1 (actin-interacting protein 1).
Figure 4Validation of predicted partner using western blot and IHC.
A. Western blot result of ROCK1 and RhoA in control and ISO-CAs (n = 3, mean ± SEM, *p<0.05, two-tailed student t-test). B. Protein expression levels of ROCK1 and RhoA were determined by immunohistochemistry in control and ISO-CAs. Scale bar: 50 μm.
Figure 5Increased oxidative stress in ISO stimulated cerebral arteries (ISO-CAs).
A. NADPH-dependent O2- production was highly increased in ISO-CAs group (7.5±0.85 O2- nmol/mg protein) than control (3.6±0.40; mean ± SEM, Student's t-test, * P<0.05 vs. Con, n = 6). B. ROS-induced lipid oxidation was highly increased in ISO-CAs group. C. Oxidative DNA damage in smooth muscle cells (SMCs) from ISO-CAs was assessed by comet assay. Nuclear DNA was stained with propidium iodide and examined under a confocal laser scanning microscope. More highly damaged DNA was observed in SMCs from ISO-CAs (c, d) compared to the control (a, b) based on tail length. Magnification: 100× for a and c, 500× for b and d. D. Statistical summary obtained from comet image analysis. Less damaged cells, class I, were significantly more common in control (65.1±5.9%) than in ISO- (47.5±3.6%) CAs, whereas severely damaged cells, class IV, were markedly more frequent in ISO-CAs (24.7±1.3%) than in the control (9.5±3.2%; mean ± SEM, Student’s t-test, * P<0.05 vs. Con, n = 4).
Figure 6Altered arterial contractility to a vasoconstrictor (Ang II) in ISO-CAs.
A. Representative trace of Ang II dose response vascular contraction in control and ISO-CAs. B. Line graph of contractile dose response to Ang II in control and ISO-CAs. (n = 4, mean ± SEM, two-way ANOVA test, *P<0.05). C. Ang II–induced intracellular calcium peak changes in control and ISO-CAs. D. Quantitative group data of calcium release, Ang II-induced [Ca2+]i change calculated by Δ(peak340/380-basal340/380) of each group. (n = 4, mean ± SEM, Student's t-test,*P<0.05). E. F. Intracellular calcium changes were measured by confocal microscopy in basal and after 20 min of Ang II treatment. ISO-CAs has lower response to Ang II-induced intracellular calcium increase (52.35±1.23 vs. 25.76±2.12, n = 4, Student's t-test,*P<0.05). G. Ang II-induced ROS productions were measured by confocal microscopy in basal (0 min) and after 10 and 20 min of Ang II treatment. ISO-CAs has lower response to Ang II-induced ROS production.
Figure 7Schematic illustration of β-adrenergic overstimulation-induced vascular dysfunction.